PNC Financial Services Group
SGNT

PNC Financial Services Group’s SAGENT PHARMACEUTICALS INC COM STK (DE) SGNT Stock Holding History

PNC Financial Services Group’s Portfolio SGNT Stock Details SGNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-106
Closed -$2K – 4588
2016
Q2 		$2K Sell
106
-4
-4% -$51 ﹤0.01% 4304
2016
Q1 		$1K Sell
110
-1,039
-90% -$14.6K ﹤0.01% 4463
2015
Q4 		$19K Buy
1,149
+1,043
+984% +$16.4K ﹤0.01% 3342
2015
Q3 		$2K Sell
106
-392
-79% -$8.47K ﹤0.01% 4389
2015
Q2 		$12K Buy
498
+415
+500% +$9.94K ﹤0.01% 3751
2015
Q1 		$2K Sell
83
-27,016
-100% -$715K ﹤0.01% 4389
2014
Q4 		$681K Buy
27,099
+27,029
+38,613% +$793K ﹤0.01% 1380
2014
Q3 		$2K Hold
70
– – ﹤0.01% 3751
2014
Q2 		$2K Hold
70
– – ﹤0.01% 3606
2014
Q1 		$2K Buy
+70
New +$1.53K ﹤0.01% 3586

PNC Financial Services Group's SGNT Position: Q3 2016 in Review

PNC Financial Services Group sold out of SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) in Q3 2016, closing a stake of 106 shares — an estimated $2K sold.

PNC Financial Services Group first reported a position in SGNT in Q1 2014 and held it in 10 quarters. The position peaked at $681K in Q4 2014. 0 funds tracked by Wall St. Rank hold SGNT as of Q3 2016.

  • PNC Financial Services Group reported no remaining SAGENT PHARMACEUTICALS INC COM STK (DE) position as of Q3 2016 after selling out during the quarter.
  • PNC Financial Services Group sold 106 SAGENT PHARMACEUTICALS INC COM STK (DE) shares in Q3 2016, an estimated $2K.
  • PNC Financial Services Group first reported a position in SAGENT PHARMACEUTICALS INC COM STK (DE) in Q1 2014 and held it in 10 quarters.
  • PNC Financial Services Group's SAGENT PHARMACEUTICALS INC COM STK (DE) position peaked at $681K in Q4 2014.
  • 0 funds tracked by Wall St. Rank held SAGENT PHARMACEUTICALS INC COM STK (DE) as of Q3 2016.

Based on PNC Financial Services Group's 13F filing for Q3 2016, filed 4 Nov 2016.